[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Follicle Stimulating Hormone Market Report 2018

March 2018 | 102 pages | ID: U573D031F58EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Follicle Stimulating Hormone market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Follicle Stimulating Hormone in these regions, from 2013 to 2025 (forecast).
United States Follicle Stimulating Hormone market competition by top manufacturers/players, with Follicle Stimulating Hormone sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Merck Serono
  • MSD
  • IBSA
  • Ferring
  • Livzon
  • Techwell
  • GenSci
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Recombinant FSH
  • Urinary FSH
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Infertility Treatment
  • Assisted Reproductive Technology
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Follicle Stimulating Hormone Market Report 2018

1 FOLLICLE STIMULATING HORMONE OVERVIEW

1.1 Product Overview and Scope of Follicle Stimulating Hormone
1.2 Classification of Follicle Stimulating Hormone by Product Category
  1.2.1 United States Follicle Stimulating Hormone Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Follicle Stimulating Hormone Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Recombinant FSH
  1.2.4 Urinary FSH
1.3 United States Follicle Stimulating Hormone Market by Application/End Users
  1.3.1 United States Follicle Stimulating Hormone Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Infertility Treatment
  1.3.3 Assisted Reproductive Technology
1.4 United States Follicle Stimulating Hormone Market by Region
  1.4.1 United States Follicle Stimulating Hormone Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Follicle Stimulating Hormone Status and Prospect (2013-2025)
  1.4.3 Southwest Follicle Stimulating Hormone Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Follicle Stimulating Hormone Status and Prospect (2013-2025)
  1.4.5 New England Follicle Stimulating Hormone Status and Prospect (2013-2025)
  1.4.6 The South Follicle Stimulating Hormone Status and Prospect (2013-2025)
  1.4.7 The Midwest Follicle Stimulating Hormone Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Follicle Stimulating Hormone (2013-2025)
  1.5.1 United States Follicle Stimulating Hormone Sales and Growth Rate (2013-2025)
  1.5.2 United States Follicle Stimulating Hormone Revenue and Growth Rate (2013-2025)

2 UNITED STATES FOLLICLE STIMULATING HORMONE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Follicle Stimulating Hormone Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Follicle Stimulating Hormone Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Follicle Stimulating Hormone Average Price by Players/Suppliers (2013-2018)
2.4 United States Follicle Stimulating Hormone Market Competitive Situation and Trends
  2.4.1 United States Follicle Stimulating Hormone Market Concentration Rate
  2.4.2 United States Follicle Stimulating Hormone Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Follicle Stimulating Hormone Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES FOLLICLE STIMULATING HORMONE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Follicle Stimulating Hormone Sales and Market Share by Region (2013-2018)
3.2 United States Follicle Stimulating Hormone Revenue and Market Share by Region (2013-2018)
3.3 United States Follicle Stimulating Hormone Price by Region (2013-2018)

4 UNITED STATES FOLLICLE STIMULATING HORMONE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Follicle Stimulating Hormone Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Follicle Stimulating Hormone Revenue and Market Share by Type (2013-2018)
4.3 United States Follicle Stimulating Hormone Price by Type (2013-2018)
4.4 United States Follicle Stimulating Hormone Sales Growth Rate by Type (2013-2018)

5 UNITED STATES FOLLICLE STIMULATING HORMONE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Follicle Stimulating Hormone Sales and Market Share by Application (2013-2018)
5.2 United States Follicle Stimulating Hormone Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES FOLLICLE STIMULATING HORMONE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck Serono
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Follicle Stimulating Hormone Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 MSD
  6.2.2 Follicle Stimulating Hormone Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 MSD Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 IBSA
  6.3.2 Follicle Stimulating Hormone Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Ferring
  6.4.2 Follicle Stimulating Hormone Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Livzon
  6.5.2 Follicle Stimulating Hormone Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Techwell
  6.6.2 Follicle Stimulating Hormone Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 GenSci
  6.7.2 Follicle Stimulating Hormone Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 FOLLICLE STIMULATING HORMONE MANUFACTURING COST ANALYSIS

7.1 Follicle Stimulating Hormone Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Follicle Stimulating Hormone

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Follicle Stimulating Hormone Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Follicle Stimulating Hormone Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES FOLLICLE STIMULATING HORMONE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Follicle Stimulating Hormone Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Follicle Stimulating Hormone Sales Volume Forecast by Type (2018-2025)
11.3 United States Follicle Stimulating Hormone Sales Volume Forecast by Application (2018-2025)
11.4 United States Follicle Stimulating Hormone Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Follicle Stimulating Hormone
Figure United States Follicle Stimulating Hormone Market Size (K Doses) by Type (2013-2025)
Figure United States Follicle Stimulating Hormone Sales Volume Market Share by Type (Product Category) in 2017
Figure Recombinant FSH Product Picture
Figure Urinary FSH Product Picture
Figure United States Follicle Stimulating Hormone Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Follicle Stimulating Hormone by Application in 2017
Figure Infertility Treatment Examples
Table Key Downstream Customer in Infertility Treatment
Figure Assisted Reproductive Technology Examples
Table Key Downstream Customer in Assisted Reproductive Technology
Figure United States Follicle Stimulating Hormone Market Size (Million USD) by Region (2013-2025)
Figure The West Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Follicle Stimulating Hormone Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Follicle Stimulating Hormone Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Follicle Stimulating Hormone Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Follicle Stimulating Hormone Sales Share by Players/Suppliers
Figure 2017 United States Follicle Stimulating Hormone Sales Share by Players/Suppliers
Figure United States Follicle Stimulating Hormone Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Follicle Stimulating Hormone Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Follicle Stimulating Hormone Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Follicle Stimulating Hormone Revenue Share by Players/Suppliers
Figure 2017 United States Follicle Stimulating Hormone Revenue Share by Players/Suppliers
Table United States Market Follicle Stimulating Hormone Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Follicle Stimulating Hormone Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Follicle Stimulating Hormone Market Share of Top 3 Players/Suppliers
Figure United States Follicle Stimulating Hormone Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Follicle Stimulating Hormone Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Follicle Stimulating Hormone Product Category
Table United States Follicle Stimulating Hormone Sales (K Doses) by Region (2013-2018)
Table United States Follicle Stimulating Hormone Sales Share by Region (2013-2018)
Figure United States Follicle Stimulating Hormone Sales Share by Region (2013-2018)
Figure United States Follicle Stimulating Hormone Sales Market Share by Region in 2017
Table United States Follicle Stimulating Hormone Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Follicle Stimulating Hormone Revenue Share by Region (2013-2018)
Figure United States Follicle Stimulating Hormone Revenue Market Share by Region (2013-2018)
Figure United States Follicle Stimulating Hormone Revenue Market Share by Region in 2017
Table United States Follicle Stimulating Hormone Price (USD/Dose) by Region (2013-2018)
Table United States Follicle Stimulating Hormone Sales (K Doses) by Type (2013-2018)
Table United States Follicle Stimulating Hormone Sales Share by Type (2013-2018)
Figure United States Follicle Stimulating Hormone Sales Share by Type (2013-2018)
Figure United States Follicle Stimulating Hormone Sales Market Share by Type in 2017
Table United States Follicle Stimulating Hormone Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Follicle Stimulating Hormone Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Follicle Stimulating Hormone by Type (2013-2018)
Figure Revenue Market Share of Follicle Stimulating Hormone by Type in 2017
Table United States Follicle Stimulating Hormone Price (USD/Dose) by Types (2013-2018)
Figure United States Follicle Stimulating Hormone Sales Growth Rate by Type (2013-2018)
Table United States Follicle Stimulating Hormone Sales (K Doses) by Application (2013-2018)
Table United States Follicle Stimulating Hormone Sales Market Share by Application (2013-2018)
Figure United States Follicle Stimulating Hormone Sales Market Share by Application (2013-2018)
Figure United States Follicle Stimulating Hormone Sales Market Share by Application in 2017
Table United States Follicle Stimulating Hormone Sales Growth Rate by Application (2013-2018)
Figure United States Follicle Stimulating Hormone Sales Growth Rate by Application (2013-2018)
Table Merck Serono Basic Information List
Table Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Serono Follicle Stimulating Hormone Sales Growth Rate (2013-2018)
Figure Merck Serono Follicle Stimulating Hormone Sales Market Share in United States (2013-2018)
Figure Merck Serono Follicle Stimulating Hormone Revenue Market Share in United States (2013-2018)
Table MSD Basic Information List
Table MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure MSD Follicle Stimulating Hormone Sales Growth Rate (2013-2018)
Figure MSD Follicle Stimulating Hormone Sales Market Share in United States (2013-2018)
Figure MSD Follicle Stimulating Hormone Revenue Market Share in United States (2013-2018)
Table IBSA Basic Information List
Table IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure IBSA Follicle Stimulating Hormone Sales Growth Rate (2013-2018)
Figure IBSA Follicle Stimulating Hormone Sales Market Share in United States (2013-2018)
Figure IBSA Follicle Stimulating Hormone Revenue Market Share in United States (2013-2018)
Table Ferring Basic Information List
Table Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Ferring Follicle Stimulating Hormone Sales Growth Rate (2013-2018)
Figure Ferring Follicle Stimulating Hormone Sales Market Share in United States (2013-2018)
Figure Ferring Follicle Stimulating Hormone Revenue Market Share in United States (2013-2018)
Table Livzon Basic Information List
Table Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Livzon Follicle Stimulating Hormone Sales Growth Rate (2013-2018)
Figure Livzon Follicle Stimulating Hormone Sales Market Share in United States (2013-2018)
Figure Livzon Follicle Stimulating Hormone Revenue Market Share in United States (2013-2018)
Table Techwell Basic Information List
Table Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Techwell Follicle Stimulating Hormone Sales Growth Rate (2013-2018)
Figure Techwell Follicle Stimulating Hormone Sales Market Share in United States (2013-2018)
Figure Techwell Follicle Stimulating Hormone Revenue Market Share in United States (2013-2018)
Table GenSci Basic Information List
Table GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GenSci Follicle Stimulating Hormone Sales Growth Rate (2013-2018)
Figure GenSci Follicle Stimulating Hormone Sales Market Share in United States (2013-2018)
Figure GenSci Follicle Stimulating Hormone Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Follicle Stimulating Hormone
Figure Manufacturing Process Analysis of Follicle Stimulating Hormone
Figure Follicle Stimulating Hormone Industrial Chain Analysis
Table Raw Materials Sources of Follicle Stimulating Hormone Major Players/Suppliers in 2017
Table Major Buyers of Follicle Stimulating Hormone
Table Distributors/Traders List
Figure United States Follicle Stimulating Hormone Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Follicle Stimulating Hormone Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Follicle Stimulating Hormone Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Follicle Stimulating Hormone Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Follicle Stimulating Hormone Sales Volume (K Doses) Forecast by Type in 2025
Table United States Follicle Stimulating Hormone Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Follicle Stimulating Hormone Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Follicle Stimulating Hormone Sales Volume (K Doses) Forecast by Application in 2025
Table United States Follicle Stimulating Hormone Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Follicle Stimulating Hormone Sales Volume Share Forecast by Region (2018-2025)
Figure United States Follicle Stimulating Hormone Sales Volume Share Forecast by Region (2018-2025)
Figure United States Follicle Stimulating Hormone Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications